These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 25944318)

  • 1. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
    Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
    HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study.
    Hattab S; Guihot A; Guiguet M; Fourati S; Carcelain G; Caby F; Marcelin AG; Autran B; Costagliola D; Katlama C
    BMC Infect Dis; 2014 Mar; 14():122. PubMed ID: 24589015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
    Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
    PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants.
    Steel HC; Venter WDF; Theron AJ; Anderson R; Feldman C; Kwofie L; Cronjé T; Arullapan N; Rossouw TM
    Mediators Inflamm; 2018; 2018():8357109. PubMed ID: 30622435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
    Thiébaut R; Charpentier C; Damond F; Taieb A; Antoine R; Capeau J; Chêne G; Collin G; Matheron S; Descamps D; Brun-Vézinet F;
    Clin Infect Dis; 2012 Nov; 55(10):1417-25. PubMed ID: 22911639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.
    Carsenti-Dellamonica H; Saïdi H; Ticchioni M; Guillouet de Salvador F; Dufayard Cottalorda J; Garraffo R; Dellamonica P; Durant J; Gougeon ML
    HIV Med; 2011 Feb; 12(2):65-77. PubMed ID: 20500532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers.
    Makhubele TG; Steel HC; Anderson R; van Dyk G; Theron AJ; Rossouw TM
    Mediators Inflamm; 2016; 2016():9026573. PubMed ID: 27019552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
    Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
    Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term suppressive combined antiretroviral treatment does not normalize the serum level of soluble CD14.
    Méndez-Lagares G; Romero-Sánchez MC; Ruiz-Mateos E; Genebat M; Ferrando-Martínez S; Muñoz-Fernández MÁ; Pacheco YM; Leal M
    J Infect Dis; 2013 Apr; 207(8):1221-5. PubMed ID: 23322858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid suppression of HIV-RNA is associated with improved control of immune activation in Mozambican adults initiating antiretroviral therapy with low CD4 counts.
    Almeida JM; Letang E; Nhampossa T; Ayala E; David C; Menendez C; Gascon J; Alonso P; Naniche D
    AIDS Res Hum Retroviruses; 2011 Jul; 27(7):705-11. PubMed ID: 21091388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suboptimal Adherence to Combination Antiretroviral Therapy Is Associated With Higher Levels of Inflammation Despite HIV Suppression.
    Castillo-Mancilla JR; Brown TT; Erlandson KM; Palella FJ; Gardner EM; Macatangay BJ; Breen EC; Jacobson LP; Anderson PL; Wada NI
    Clin Infect Dis; 2016 Dec; 63(12):1661-1667. PubMed ID: 27660234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visceral leishmaniasis as an independent cause of high immune activation, T-cell senescence, and lack of immune recovery in virologically suppressed HIV-1-coinfected patients.
    Casado JL; Abad-Fernández M; Moreno S; Pérez-Elías MJ; Moreno A; Bernardino JI; Vallejo A
    HIV Med; 2015 Apr; 16(4):240-8. PubMed ID: 25604328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
    Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
    HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study.
    Wada NI; Bream JH; Martínez-Maza O; Macatangay B; Galvin SR; Margolick JB; Jacobson LP
    Clin Infect Dis; 2016 Oct; 63(7):984-990. PubMed ID: 27343547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
    de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
    Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma Biomarkers of Human Immunodeficiency Virus-Related Systemic Inflammation and Immune Activation in Sub-Saharan Africa Before and During Suppressive Antiretroviral Therapy.
    Kroeze S; Wit FW; Rossouw TM; Steel HC; Kityo CM; Siwale M; Akanmu S; Mandaliya K; de Jager M; Ondoa P; Reiss P; Rinke de Wit TF; Kootstra N; Hamers RL
    J Infect Dis; 2019 Aug; 220(6):1029-1033. PubMed ID: 31086991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities.
    Ghislain M; Bastard JP; Meyer L; Capeau J; Fellahi S; Gérard L; May T; Simon A; Vigouroux C; Goujard C;
    PLoS One; 2015; 10(12):e0144317. PubMed ID: 26636578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma CXCL10, sCD163 and sCD14 Levels Have Distinct Associations with Antiretroviral Treatment and Cardiovascular Disease Risk Factors.
    Castley A; Williams L; James I; Guelfi G; Berry C; Nolan D
    PLoS One; 2016; 11(6):e0158169. PubMed ID: 27355513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.